This website uses cookies to enhance the user experience.
B

BARNEHAGEBRØDET AS912 007 634

Research
Limited company
Greisdalslia 20 8028 BODØ, Norge

BARNEHAGEBRØDET AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
12 years
since May 30, 2013
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
102
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
163,286
NOK
Annual total result 2024
218,849
NOK
Total equity 2024
1,364,408
NOK
Last update: Jun 2, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly

Others

NameRoleShares
R
RESPONS REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Jan 16, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
102
100 %

Shares owned by the BARNEHAGEBRØDET AS

NameShare classTotal number of sharesShare
G
GIGANTE SALMON AS
NO0011013765
110,000
0.06 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year202420232022
Total operating income
163,286
205,686
243,147
Annual Total Result
218,849
-165,725
-135,571
Total assets
1,564,611
1,362,040
1,643,873
Total liabilities
200,204
66,481
182,589
Total equity
1,364,408
1,295,559
1,461,285

P&L

Year202420232022
Total operating income
163,286
205,686
243,147
Total operating costs
187,258
150,339
178,941
Operating result
-23,972
55,348
64,206
Financial income/costs
258,490
-209,409
-186,366
Profit before tax
234,518
-154,061
-122,160
Total tax & extraordinary income/cost
15,669
11,664
13,411
Annual Total Result
218,849
-165,725
-135,571

Balance overview

Year202420232022
Total fixed assets
79,931
109,931
142,106
Total current assets
1,484,680
1,252,109
1,501,767
Total assets
1,564,611
1,362,040
1,643,873
Short term debt
191,832
54,835
168,345
Long term debt
8,371
11,646
14,244
Total liabilities
200,204
66,481
182,589
Contributed capital
30,600
30,600
30,600
Retained earnings
1,333,808
1,264,959
1,430,685
Total equity
1,364,408
1,295,559
1,461,285
Total equity and liabilities
1,564,612
1,362,040
1,643,874

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology